BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6319875)

  • 1. K receptor activities of the three opioid peptide families.
    Rezvani A; Höllt V; Way EL
    Life Sci; 1983; 33 Suppl 1():271-4. PubMed ID: 6319875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opiate activity of peptides derived from the three opioid peptide families on the rat vas deferens.
    Sánchez-Blázquez P; Garzón J; Lee NM; Höllt V
    Neuropeptides; 1984 Dec; 5(1-3):181-4. PubMed ID: 6099492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the action of putative endogenous kappa-agonists, leumorphin and rimorphin in vitro.
    Suda M; Nakao K; Yoshimasa T; Ikeda Y; Sakamoto M; Yanaihara C; Yanaihara N; Numa S; Imura H
    Life Sci; 1983; 33 Suppl 1():275-8. PubMed ID: 6319876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide E and other proenkephalin-derived peptides are potent kappa opiate receptor agonists.
    Quirion R; Weiss AS
    Peptides; 1983; 4(4):445-9. PubMed ID: 6316294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that endogenous 6-(ARG or LYS)-opioid peptides can interact with kappa-receptors as agonists.
    Oka T; Negishi K
    Life Sci; 1982 Oct 18-25; 31(16-17):1707-10. PubMed ID: 6130430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid profiles of Cys2-containing enkephalin analogues.
    Pencheva N; Milanov P; Vezenkov L; Pajpanova T; Naydenova E
    Eur J Pharmacol; 2004 Sep; 498(1-3):249-56. PubMed ID: 15364002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selectivities of opioid peptide analogues as agonists and antagonists at the delta-receptor.
    Corbett AD; Gillan MG; Kosterlitz HW; McKnight AT; Paterson SJ; Robson LE
    Br J Pharmacol; 1984 Sep; 83(1):271-9. PubMed ID: 6091824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel opioid peptide, leumorphin, acts as an agonist at the kappa opiate receptor.
    Suda M; Nakao K; Yoshimasa T; Ikeda Y; Sakamoto M; Yanaihara N; Numa S; Imura H
    Life Sci; 1983 Jun; 32(24):2769-75. PubMed ID: 6134225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid activity of pro-enkephalin-derived peptides in mouse vas deferens and guinea pig ileum.
    Sánchez-Blázquez P; Garzón J
    Neurosci Lett; 1985 Nov; 61(3):267-71. PubMed ID: 3001596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human leumorphin is a potent, kappa opioid receptor agonist.
    Suda M; Nakao K; Yoshimasa T; Sakamoto M; Morii N; Ikeda Y; Yanaihara C; Yanaihara N; Numa S; Imura H
    Neurosci Lett; 1984 Sep; 50(1-3):49-52. PubMed ID: 6149506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cys(O2NH2)2]enkephalin analogues and dalargin: selectivity for delta-opioid receptors.
    Pencheva N; Bocheva A; Dimitrov E; Ivancheva C; Radomirov R
    Eur J Pharmacol; 1996 May; 304(1-3):99-108. PubMed ID: 8813590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rat vas deferens: a specific bioassay for endogenous opioid peptides.
    Lemaire S; Magnan J; Regoli D
    Br J Pharmacol; 1978 Nov; 64(3):327-9. PubMed ID: 719230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans.
    Ananthan S; Kezar HS; Carter RL; Saini SK; Rice KC; Wells JL; Davis P; Xu H; Dersch CM; Bilsky EJ; Porreca F; Rothman RB
    J Med Chem; 1999 Sep; 42(18):3527-38. PubMed ID: 10479286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of evidence for epsilon-opioid receptors in the rat vas deferens.
    Sheehan MJ; Hayes AG; Tyers MB
    Eur J Pharmacol; 1988 Sep; 154(3):237-45. PubMed ID: 2853057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Leu5]enkephalin containing peptides derived from a common precursor: evaluation of opioid activity in in vitro bioassays.
    Sanchez-Blazquez P; Garzon J; Lee NM
    Eur J Pharmacol; 1984 Mar; 98(3-4):389-96. PubMed ID: 6327333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The choice of opiate receptor subtype by neo-endorphins.
    Oka T; Negishi K; Kajiwara M; Watanabe Y; Ishizuka Y; Matsumiya T
    Eur J Pharmacol; 1982 Apr; 79(3-4):301-5. PubMed ID: 6284522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysine substitution increases mu-selectivity of potent di- and tri-peptide enkephalin analogs.
    Vavrek RJ; Cui RL; York EJ; Stewart JM; Paterson S; Kosterlitz HW
    Life Sci; 1983; 33 Suppl 1():451-4. PubMed ID: 6319902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective ligands for opioid receptors. beta-Cyclopropylalanyl containing analogs of enkephalin.
    Muthukumaraswamy N; Day AR; Pinon D; Liao CS; Freer RJ
    Int J Pept Protein Res; 1983 Sep; 22(3):305-12. PubMed ID: 6313538
    [No Abstract]   [Full Text] [Related]  

  • 19. Assessment of the kappa-opioid activity of a series of 6,7-benzomorphans in the rabbit vas deferens.
    Verlinde C; De Ranter C
    Eur J Pharmacol; 1988 Aug; 153(1):83-7. PubMed ID: 2850928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
    J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.